Calculating The Fair Value Of SSY Group Limited (HKG:2005)
Dec 19
Have your own idea? Try our Stock Screener
Hong Kong (HSI) Pharma Industry Analysis
UpdatedDec 21, 2024
DataAggregated Company Financials
Companies39
- 7D-1.9%
- 3M-3.4%
- 1Y-3.9%
- YTD-8.2%
Over the last 7 days, the Pharma industry has dropped 1.9%, driven by a pullback from Sino Biopharmaceutical of 2.7%. Overall the industry is down 3.9% in 12 months. As for the next few years, earnings are expected to grow by 11% per annum.
Industry Valuation and Performance
Has the Hong Kong Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 21 Dec 2024 | HK$431.9b | HK$460.4b | HK$31.8b | 8.4x | 13.6x | 0.9x |
| Mon, 18 Nov 2024 | HK$432.9b | HK$463.7b | HK$31.5b | 8.2x | 13.8x | 0.9x |
| Wed, 16 Oct 2024 | HK$487.3b | HK$471.2b | HK$32.7b | 7.8x | 14.9x | 1x |
| Fri, 13 Sep 2024 | HK$422.7b | HK$472.8b | HK$32.8b | 7.3x | 12.9x | 0.9x |
| Sun, 11 Aug 2024 | HK$440.9b | HK$463.5b | HK$32.9b | 7.4x | 13.4x | 1x |
| Tue, 09 Jul 2024 | HK$433.5b | HK$461.3b | HK$33.7b | 7.6x | 12.9x | 0.9x |
| Thu, 06 Jun 2024 | HK$471.2b | HK$463.6b | HK$33.9b | 8.3x | 13.9x | 1x |
| Sat, 04 May 2024 | HK$475.2b | HK$463.4b | HK$33.7b | 7.6x | 14.1x | 1x |
| Mon, 01 Apr 2024 | HK$445.8b | HK$465.7b | HK$36.5b | 7.7x | 12.2x | 1x |
| Wed, 28 Feb 2024 | HK$448.3b | HK$470.7b | HK$33.5b | 7.7x | 13.4x | 1x |
| Fri, 26 Jan 2024 | HK$426.9b | HK$471.9b | HK$33.7b | 7.2x | 12.7x | 0.9x |
| Sun, 24 Dec 2023 | HK$464.0b | HK$472.7b | HK$33.8b | 7.5x | 13.7x | 1x |
| Tue, 21 Nov 2023 | HK$508.8b | HK$471.7b | HK$32.2b | 7.1x | 15.8x | 1.1x |
| Thu, 19 Oct 2023 | HK$432.0b | HK$469.1b | HK$31.5b | 6.9x | 13.7x | 0.9x |
| Sat, 16 Sep 2023 | HK$424.5b | HK$470.0b | HK$31.6b | 6.7x | 13.4x | 0.9x |
| Mon, 14 Aug 2023 | HK$439.9b | HK$446.6b | HK$28.2b | 8.6x | 15.6x | 1x |
| Wed, 12 Jul 2023 | HK$478.1b | HK$446.4b | HK$27.9b | 9.5x | 17.2x | 1.1x |
| Fri, 09 Jun 2023 | HK$508.0b | HK$448.1b | HK$27.8b | 8.8x | 18.2x | 1.1x |
| Sun, 07 May 2023 | HK$571.5b | HK$453.4b | HK$28.5b | 9.2x | 20.1x | 1.3x |
| Tue, 04 Apr 2023 | HK$533.2b | HK$452.7b | HK$28.8b | 8.9x | 18.5x | 1.2x |
| Thu, 02 Mar 2023 | HK$602.3b | HK$444.7b | HK$34.2b | 11.5x | 17.6x | 1.4x |
| Sat, 28 Jan 2023 | HK$645.5b | HK$447.3b | HK$35.6b | 10.8x | 18.1x | 1.4x |
| Mon, 26 Dec 2022 | HK$585.2b | HK$441.7b | HK$34.7b | 10.6x | 16.9x | 1.3x |
| Wed, 23 Nov 2022 | HK$588.1b | HK$436.2b | HK$33.8b | 9.4x | 17.4x | 1.3x |
| Fri, 21 Oct 2022 | HK$563.0b | HK$512.2b | HK$38.8b | 8.8x | 14.5x | 1.1x |
| Sun, 18 Sep 2022 | HK$528.7b | HK$518.6b | HK$40.6b | 9.2x | 13x | 1x |
| Tue, 16 Aug 2022 | HK$585.0b | HK$513.4b | HK$51.4b | 8x | 11.4x | 1.1x |
| Thu, 14 Jul 2022 | HK$621.1b | HK$513.8b | HK$52.1b | 8.6x | 11.9x | 1.2x |
| Sat, 11 Jun 2022 | HK$583.8b | HK$514.8b | HK$52.0b | 9.1x | 11.2x | 1.1x |
| Mon, 09 May 2022 | HK$553.5b | HK$514.3b | HK$51.4b | 8.1x | 10.8x | 1.1x |
| Wed, 06 Apr 2022 | HK$653.8b | HK$525.3b | HK$53.0b | 9x | 12.3x | 1.2x |
| Fri, 04 Mar 2022 | HK$652.0b | HK$500.9b | HK$45.2b | 9.7x | 14.4x | 1.3x |
| Sun, 30 Jan 2022 | HK$653.3b | HK$496.8b | HK$43.8b | 9x | 14.9x | 1.3x |
| Tue, 28 Dec 2021 | HK$704.3b | HK$497.0b | HK$43.8b | 9.3x | 16.1x | 1.4x |
Price to Earnings Ratio
16.1x
Current Industry PE
- Investors are relatively neutral on the Hong Kong Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 14.6x.
- The 3-year average PS ratio of 1.1x is higher than the industry's current PS ratio of 0.94x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have declined 10% per year over the last three years,
- Revenues have also declined 2.5% per year.
- This means overall sales from these companies are declining and profits are subsequently falling as well.
Industry Trends
Which industries have driven the changes within the Hong Kong Healthcare industry?
| HK Market | -0.53% | |
| Healthcare | -2.00% | |
| Pharma | -1.88% | |
| Pharma | -1.88% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 512 Grand Pharmaceutical Group | HK$4.74 | 1.3% +HK$210.1m | 22.8% | PE6.9x | |
| 2633 Jacobson Pharma | HK$1.01 | 9.8% +HK$178.7m | 57.8% | PE7.9x | |
| 3320 China Resources Pharmaceutical Group | HK$5.43 | 0.4% +HK$125.7m | 12.4% | PE8.5x | |
| 1093 CSPC Pharmaceutical Group | HK$4.81 | 0.2% +HK$116.4m | -30.0% | PE10.2x | |
| 3613 Beijing Tong Ren Tang Chinese Medicine | HK$8.46 | 1.6% +HK$108.8m | -27.7% | PE14.3x |
